Study Stopped
Study DAR-312 did not meet its primary co-endpoints.
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
Darusentan
A Double-Blind, Active-Controlled, Long-Term Safety Extension Study of Optimized Doses of Darusentan in Subjects With Resistant Hypertension Despite Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic, as Compared to Guanfacine (Protocol DAR-312-E)
1 other identifier
interventional
661
4 countries
99
Brief Summary
This is a double-blind, active-controlled, long-term study of a new experimental drug called darusentan. Darusentan in not currently approved by the United States Food and Drug Administration (FDA), which means that a doctor cannot prescribe this drug. The purpose of this study is to evaluate the long-term safety of darusentan (optimized dose) as compared to an active control, administered orally.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 hypertension
Started May 2007
Longer than P75 for phase_3 hypertension
99 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2006
CompletedFirst Posted
Study publicly available on registry
October 19, 2006
CompletedStudy Start
First participant enrolled
May 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedJanuary 6, 2014
January 1, 2014
2.8 years
October 17, 2006
January 3, 2014
Conditions
Outcome Measures
Primary Outcomes (3)
Change from baseline in mean 24-hour systolic and diastolic ambulatory blood pressure
Baseline to Week 14
Percentage of subjects who reach systolic blood pressure goal
Week 14
Change from baseline in estimated glomerular filtration rate (eGFR)
Baseline to Week 14
Secondary Outcomes (1)
Change from baseline in trough sitting systolic and diastolic blood pressures
Baseline to Week 14
Study Arms (2)
Darusentan
EXPERIMENTALDarusentan capsules titrated to an optimal dose of 50 mg, 100 mg, or 300 mg administered orally once daily
Guanfacine
ACTIVE COMPARATORGuanfacine 1 mg capsules administered orally once daily
Interventions
Darusentan capsules at a dose of 50, 100, or 300 mg administered orally once daily
Eligibility Criteria
You may qualify if:
- Subjects must be competent to provide written informed consent;
- Subjects must have completed the Maintenance Period of the DAR-312 study.
You may not qualify if:
- Subjects who discontinue treatment with study drug prior to the end of the Maintenance Period in DAR-312 due to a study drug-related AE;
- Subjects who experience a study drug-related serious adverse event (SAE) during the DAR-312 study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gilead Scienceslead
Study Sites (99)
Alabama Internal Medicine, PC
Birmingham, Alabama, 35235, United States
Greystone Medical Research, LLC
Birmingham, Alabama, 35242, United States
The Heart Center, PC
Huntsville, Alabama, 35801, United States
Mulberry Medical Associates, PC
Montgomery, Alabama, 36106, United States
Arizona Center for Clinical Research
Glendale, Arizona, 85306, United States
Cardiovascular Consultants, Ltd.
Glendale, Arizona, 85306, United States
Lovelace Scientific Resource, Inc.
Phoenix, Arizona, 85016, United States
Cochise Clinical Research
Sierra Vista, Arizona, 85635, United States
Southwest Heart
Tucson, Arizona, 85715, United States
HealthFirst Physicians of AR, PA dba Convenient Care Clinic
Hot Springs, Arkansas, 71913, United States
NEA Clinical
Jonesboro, Arkansas, 72401, United States
Arkansas Primary Care Clinic, PA
Little Rock, Arkansas, 72204, United States
Medical Investigators, Inc.
Little Rock, Arkansas, 72205, United States
Highgrove Medical Center
Bakersfield, California, 93301, United States
Central Cardiology Medical Clinic
Bakersfield, California, 93308, United States
Impact Clinical Trials
Beverly Hills, California, 90211, United States
VA Greater Los Angeles Healthcare System
Los Angeles, California, 90073, United States
Rancho Cucamonga Clinical Trials
Rancho Cucamonga, California, 91730, United States
Pacific Heart Institute
Santa Monica, California, 90404, United States
Los angeles biomedical research Institute at Harbor-UCLA Medical Center
Torrance, California, 90502, United States
Aurora Denver Cardiology Associates
Aurora, Colorado, 80012, United States
Aurora Denver Cardiology Associates
Denver, Colorado, 80218, United States
Clinical Research of South Florida
Coral Gables, Florida, 33134, United States
Doctors Medical center of Walton County
DeFuniak Springs, Florida, 32435, United States
Broward General Medical Center
Fort Lauderdale, Florida, 33316, United States
Maxine Hamilton, MD, PA
Fort Lauderdale, Florida, 33316, United States
St John's Center for Clinical Research
Jacksonville, Florida, 32259, United States
Private Practice of Dr. Bridget Bellingar
Largo, Florida, 33773, United States
A + Research Inc.
Miami, Florida, 33144, United States
AppleMed Research, Inc.
Miami, Florida, 33155, United States
Internal Medicine Associates of South Florida
North Miami Beach, Florida, 33179, United States
Ormond Medical Arts Pharmaceutical Research Center
Ormond Beach, Florida, 32174, United States
Nothwest Florida Heart Group, PA-Research Dept
Pensacola, Florida, 32514, United States
Cardiovascular Center of Sarasota
Sarasota, Florida, 34231, United States
Suncoast Cardiovascular Research, Inc
St. Petersburg, Florida, 33701, United States
Tampa Bay Nephrology Associates, PL
Tampa, Florida, 33603, United States
Orlando Rangel, MD, PA
Tampa, Florida, 33607, United States
AMR Research Associates, LLC
Bogart, Georgia, 30622, United States
Atlanta Vascular Research Foundation
Tucker, Georgia, 30084, United States
Consultants in Cardiovascular Med (CIS)
Melrose Park, Illinois, 60160, United States
Illinois Heart & Lunch Research Center
Normal, Illinois, 61761, United States
Methodist Medical Center-Heart, Lung & Vascular Institute
Peoria, Illinois, 61606, United States
Medical consultants, PC
Muncie, Indiana, 47303, United States
University Medical Associates
Louisville, Kentucky, 40202, United States
Dr. Jeffrey Chen
Lafayette, Louisiana, 70503, United States
Louisiana Research Associates, Inc.
New Orleans, Louisiana, 70114, United States
Maine Research Associates
Auburn, Maine, 04210, United States
PrimeCare Internal Medicine
Biddeford, Maine, 04005, United States
Great Lakes Heart Center of Alpena
Alpena, Michigan, 49707, United States
Internal Medicine of Northern Michigan
Petoskey, Michigan, 49770, United States
Minneapolis VAMC
Minneapolis, Minnesota, 55417, United States
Central Minnesota Heart Center at St. Cloud Hospital
Saint Cloud, Minnesota, 56303, United States
St. Paul Cardiology
Saint Paul, Minnesota, 55102, United States
Glacier View Cardiology, PC
Kalispell, Montana, 59901, United States
Impact Clinical Trials
Las Vegas, Nevada, 89106, United States
NJ Heart
Linden, New Jersey, 07036, United States
New Jersey Physicians
Passaic, New Jersey, 07055, United States
Lifeline Research Institute
Brooklyn, New York, 11214, United States
Metrolina Internal Medicine, PA
Charlotte, North Carolina, 28204, United States
Heart Care Center of Charlotte
Charlotte, North Carolina, 28211, United States
Physicians East, PA
Winterville, North Carolina, 27858, United States
Plaza Medical Group, PC
Oklahoma City, Oklahoma, 73112, United States
Castlerock Clinical Research Consultants, LLC
Tulsa, Oklahoma, 74136, United States
Integrated Medical Research PC
Ashland, Oregon, 97520, United States
Blackstone Cardiology Associates
Pawtucket, Rhode Island, 02860, United States
Charleston Cardiology
Charleston, South Carolina, 29403, United States
Paris View Family Practice
Greenville, South Carolina, 29601, United States
Internal Medicine of Greer
Greer, South Carolina, 29651, United States
Scenic City Research
Cleveland, Tennessee, 37311, United States
Southeast Texas Clinical Research Center
Beaumont, Texas, 77702, United States
Cardiovascular Research Inst. of Dallas
Dallas, Texas, 75231, United States
Galenos Research
Dallas, Texas, 75251, United States
Sergio F Rovner, MD
El Paso, Texas, 79935, United States
Salim Gopalani, MD, PA
Houston, Texas, 77008, United States
Humayum Mirza, MD, PA
Houston, Texas, 77055, United States
Clinical Trial Network
Houston, Texas, 77074, United States
Houston Clinical Research Assoc.
Houston, Texas, 77090, United States
Innovative Research of West Florida
Hurst, Texas, 76054, United States
North Texas Medical Research
Plano, Texas, 75093, United States
Scott & White Memorial Hospital
Temple, Texas, 76508, United States
Fletcher Allen Health Care/University of Vermont
Burlington, Vermont, 05401, United States
Kamlesh N Dave Cardiology
Hopewell, Virginia, 23860, United States
WVU Physicicans of Charleston
Charleston, West Virginia, 25304, United States
Alpha Medical Research, LLC
Madison, Wisconsin, 43717, United States
Executive Health and Research Associates
Madison, Wisconsin, 53717, United States
Instituto de Investigaciones Clinicas Bahia Blanca
Bahía Blanca, Argentina
Consultorios Medicos Privados S.A.
Buenos Aires, Argentina
Policlinica Bancaria "9 de Julio"
Buenos Aires, Argentina
Diabaid (Instituto de Asistencia Integral en Diabetes)
Ciudad de Buenos Aires, Argentina
MD Investigaciones
Ciudad de Buenos Aires, Argentina
Instituto de Cardiologia de Corrientes
Corrientes, Argentina
Framingham Centro Medico
La Plata, Argentina
Instituto de Investigaciones Clinicas Mar del Plata
Mar del Plata, Argentina
Instituto de Investigaciones Clinicas de Quilmes
Quilmes, Argentina
Instituto de Investigaciones Clinicas
Rosario, Argentina
Centro de Investigaciones clincas de Litoral
Santa Fe, Argentina
Flinders Medical Centre
Bedford, Australia
Royal Perth Hospital
Perth, Australia
Private Practice of Dr. Herwig Van Aerde
Rio de Janeiro, Brazil
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2006
First Posted
October 19, 2006
Study Start
May 1, 2007
Primary Completion
February 1, 2010
Study Completion
May 1, 2010
Last Updated
January 6, 2014
Record last verified: 2014-01